Issaquah, WA, United States of America

Thomas P St John

This inventor holds 5 USPTO granted patents. Top assignee: Fred Hutchinson Cancer Center. Active years: 1991-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1991-1999

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Thomas P St John

Introduction

Thomas P St John is a notable inventor based in Issaquah, WA (US). He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic methods using antibodies. With a total of 5 patents to his name, his work has had a profound impact on medical science.

Latest Patents

Among his latest patents are innovative methods involving CD44-specific antibodies. These patents include "Methods of using CD44-specific antibodies - Therapeutic methods using antibodies to an adhesion receptor for high endothelial venules (HEV)" and "Fragments of a lymphocyte adhesion receptor for high endothelium, CD44 - A lymphoid cell line cDNA that encodes an adhesion receptor for high endothelial venules (HEV)." These inventions highlight his focus on enhancing therapeutic approaches in medicine.

Career Highlights

Thomas P St John is affiliated with the Fred Hutchinson Cancer Center, where he continues to advance his research. His work at this prestigious institution has allowed him to explore various avenues in cancer research and treatment.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including W Michael Gallatin and Rejean L Idzerda. These partnerships have fostered a collaborative environment that promotes innovation and discovery in the field.

Conclusion

Thomas P St John is a distinguished inventor whose work has significantly contributed to the advancement of therapeutic methods in medicine. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…